Flagship Harbor Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-354
Closed -$31.8K 2238
2025
Q4
$31.8K Buy
+354
New +$33.6K ﹤0.01% 1191
2020
Q4
Sell
-524
Closed -$69K 1812
2020
Q3
$69K Sell
524
-67
-11% -$8.75K 0.01% 758
2020
Q2
$68K Buy
591
+63
+12% +$7.26K 0.01% 765
2020
Q1
$52K Buy
528
+394
+294% +$51.6K 0.01% 743
2019
Q4
$19K Buy
134
+63
+89% +$8.7K ﹤0.01% 1133
2019
Q3
$9K Hold
71
﹤0.01% 1330
2019
Q2
$8K Hold
71
﹤0.01% 1384
2019
Q1
$8K Hold
71
﹤0.01% 1378
2018
Q4
$7K Sell
71
-11
-13% -$1.24K ﹤0.01% 1368
2018
Q3
$10K Sell
82
-24
-23% -$2.85K ﹤0.01% 1435
2018
Q2
$11K Buy
+106
New +$11.5K ﹤0.01% 1351

Other funds holding ZBH

Flagship Harbor Advisors's ZBH Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 354 shares — an estimated $31.8K sold.

Flagship Harbor Advisors first reported a position in ZBH in Q2 2018 and held it in 11 quarters. The position peaked at $69K in Q3 2020. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 354 Zimmer Biomet shares in Q1 2026, an estimated $31.8K.
  • Flagship Harbor Advisors first reported a position in Zimmer Biomet in Q2 2018 and held it in 11 quarters.
  • Flagship Harbor Advisors's Zimmer Biomet position peaked at $69K in Q3 2020.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.